Colson 1992.
Methods | Prospective randomized controlled trial | |
Participants | Scheduled for infrarenal aortic surgery because of aortic aneurysm (n = 8) or aorta occlusive disease (n = 16) Mean age (years): 1. 63 ± 1; 2. 63 ± 3; 3. 58 ± 4 Sample size (male): 24(23) |
|
Interventions | 2 days before surgery, participants were allocated to 1 of 3 groups in randomized, double‐blind fashion: 1. control group; 2. nicardipine group; 3. enalapril group. The enalapril group received enalapril (10 mg twice daily), whereas the control and nicardipine groups received a placebo (1 tablet twice daily). The last dose of either enalapril or placebo was given at the time of preanaesthetic medication, approximately 2 h before surgery. Both treatments were well tolerated. At skin incision, nicardipine was administered to the nicardipine group (2 mg IV bolus injection, then 2 mg/h), and placebo (5% glucose solution) was infused in participants in the other groups | |
Outcomes | Glomerular filtration rate | |
Notes | Intervention started 2 days before surgery and continued until 2 h before surgery | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Random allocation, but no details available |
Allocation concealment (selection bias) | Unclear risk | No relevant description, and no further details available |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double blind, but no details available |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No relevant description |
Incomplete outcome data (attrition bias) All outcomes | High risk | No relevant description |
Selective reporting (reporting bias) | Unclear risk | Protocol inaccessible |
Other bias | Unclear risk | Funding source not reported |